← FDA Drug Approvals (Drugs@FDA)
DEFLAZACORT
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2025-12-12
Drug application
- FDA Application #
ANDA217173- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DEFLAZACORT
- Generic name
- DEFLAZACORT
- Active ingredients
- DEFLAZACORT
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- AMNEAL
- Manufacturer
- Amneal Pharmaceuticals NY LLC
- First approval
- 2025-12-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown